Regulation & Compliance

A new AI biomarker analyzes blood vessels in CT scans, offering earlier, more accurate predictions of which patients will benefit from immunotherapy.

Evie Wang, the marketing and product mind behind Retell AI's explosive growth, earns a top spot on Inc.'s prestigious list of women business leaders.

As quantum threats and automation demands reshape cybersecurity, Sectigo appoints a new leader to capitalize on record growth and guide its global expansion.

Terra Security's new desktop app lets human pentesters direct AI agents, promising to slash vulnerability remediation from months to mere hours.

With a new Chief Growth Officer and major investor backing, Guidelight Health is poised for aggressive expansion in the booming mental health care market.

Tenax Therapeutics achieves a major clinical trial goal, moving its promising drug TNX-103 closer to becoming the first approved therapy for a deadly heart condition.

A new survey finds companies are dynamically adjusting investment hurdles in response to market chaos, leveraging technology to navigate an uncertain world.

BriefCatch launches RealityCheck, a new tool to combat AI-generated legal errors as courts increasingly sanction lawyers for submitting fabricated citations.

As food prices surge, gofer.run uses AI to find the cheapest grocery basket across multiple stores, promising to save families hundreds each month.

After selling assets and raising cash, Q32 Bio focuses all its resources on bempikibart, a novel drug for hair loss, with pivotal data due in 2026.

As ATCO's Viva Homes aims to tackle the housing crisis, its new partnership with ComplyWorks embeds digital safety and compliance at the core of its strategy.

Glasswall's new AI solution, Foresight, promises to predict unknown malware by analyzing file DNA, shifting security from reactive to proactive defense.

Uranium Energy Corp reports a strong quarter with new mine completion, robust finances, and a strategic push to build a fully domestic nuclear fuel cycle.

A new line of ultra-pure proteins with endotoxin levels 10x below the standard could revolutionize advanced therapies and fix a key source of error in science.

For the 12th straight year, Taiwan's E.SUN is in the S&P Sustainability Yearbook, ranking in the top 1% of banks and setting a new global standard.

In just four months, digital asset platform Sambaex has captured a million users in Brazil, signaling a new era for crypto adoption in Latin America.

Telehealth firm Direct Meds offers cheap GLP-1 drugs, but an FDA warning for "false claims" and the end of drug shortages cast a long shadow on its model.

After 15 years without new therapies, Tonix Pharma's TONMYA enters the fibromyalgia market with a unique sublingual drug and an ambitious commercial plan.

AEON Biopharma hires a seasoned CFO to navigate FDA trials and financial hurdles as it aims to launch its BOTOX biosimilar into a lucrative market.

A Texas hospital settled with an employee denied a religious exemption for a flu shot, highlighting a growing legal war over individual rights and public health.